Lv4
610 积分 2025-07-04 加入
Multicentre, randomised phaseIIIstudy of the efficacy and safety of eltrombopag in Chinese patients with chronic immune thrombocytopenia
2天前
已完结
Efficacy and Safety of Eltrombopag in Chinese Patients with Chronic Immune Thrombocytopenia: Stage 2 Results from a Multicenter Phase III Study
2天前
已关闭
Manipulating CD38 ectoenzymatic activity revitalizes regulatory T cells via deacetylase Sirt-1 in immune thrombocytopenia
26天前
已完结
Avatrombopag plus fostamatinib combination as treatment in patients with multirefractory immune thrombocytopenia
27天前
已完结
Eltrombopag therapy in newly diagnosed steroid non-responsive ITP patients
1个月前
已完结
Novel therapies for immune thrombocytopenia
2个月前
已完结
Inhibition of Spleen Tyrosine Kinase Reduces Renal Allograft Injury in a Rat Model of Acute Antibody-Mediated Rejection in Sensitized Recipients
2个月前
已完结
Inhibition of Spleen Tyrosine Kinase Reduces Renal Allograft Injury in a Rat Model of Acute Antibody-Mediated Rejection in Sensitized Recipients
2个月前
已完结
Inhibition of spleen tyrosine kinase decreases donor specific antibody levels in a rat model of sensitization
2个月前
已完结
皖公网安备34019202002308
